A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
Clinical trial NCT06169891 · UNKNOWN
Trial details
- NCT number
- NCT06169891
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.